ISTANBUL China on Friday approved its first implantable brain-computer interface device, marking a key milestone in the country’s push to compete with US firms in neurotechnology. China’s drug regulator, the National Medical Products Administration, said it approved a brain implant developed by Neuracle Medical Technology for adult patients with partial paralysis caused by spinal cord injuries. During clinical trials, patients using Neuracle’s brain-computer interface (BCI) showed improved